SCHEMBL7008562

SCHEMBL7008562

CCOC(=O)CC(=O)N1CCCNCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.47
TSHR P16473 2/20 0.43
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
TPSAB1 Q15661 1/20 0.42
TPSD1 Q9BZJ3 1/20 0.42
TPSG1 Q9NRR2 1/20 0.42
POLB P06746 3/20 0.42
LMNA P02545 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CA2 P00918 2/20 0.41
CHKA P35790 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.39
RAB9A P51151 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PRKCA P17252 1/20 0.39
GSK3B P49841 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL223339 0.94 ALOX15 (0.51) ALOX15TSHRMGAMGAASI
Hydrochloric Acid SCHEMBL223338 0.92 ALOX15 (0.50) ALOX15TSHRMGAMGAASI
SCHEMBL11191041 0.85 ALOX15 (0.56) ALOX15TSHRMGAMGAASI
SCHEMBL11191103 0.83 ALOX15 (0.54) ALOX15TSHRMGAMGAASI
SCHEMBL9527006 0.83 ALOX15 (0.54) ALOX15TSHRMGAMGAASI
SCHEMBL1143951 0.82 TSHR (0.50) TSHRGAAPOLBLMNAALDH1A1
Hydrochloric Acid SCHEMBL28954178 0.80 TSHR (0.49) TSHRGAAPOLBLMNAALDH1A1
SCHEMBL14905948 0.79 TSHR (0.66) TSHRGAATPSAB1TPSD1TPSG1
SCHEMBL6669605 0.78 CA2 (0.47) GAATPSAB1TPSD1TPSG1CA2
SCHEMBL999224 0.78 TPSAB1 (0.50) MGAMGAASIMGAM2TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224186-B1 PYRIDYL-CONTAINING SPIROCYCLIC COMPOUNDS AS INHIBITORS OF FIBRINOGEN-DEPENDENT PLATELET AGGREGATION MILLENNIUM PHARM INC (US) 2003-09-24 EP disclosed
US-20030055244-A1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation MILLENNIUM PHARMACEUTICALS, INC. 2003-03-20 US disclosed
EP-1224186-A2 PYRIDYL-CONTAINING SPIROCYCLIC COMPOUNDS AS INHIBITORS OF FIBRINOGEN-DEPENDENT PLATELET AGGREGATION COR THERAPEUTICS, INC. (US) 2002-07-24 EP disclosed
WO-2001030780-A2 PYRIDYL-CONTAINING SPIROCYCLIC COMPOUNDS AS INHIBITORS OF FIBRINOGEN-DEPENDENT PLATELET AGGREGATION COR THERAPEUTICS, INC. (US) 2001-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055244-A1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation PF4, PFKP, FGB ALOX15 2563/4885TSHR 1147/4885MGAM 4777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.